new biomarker linked to blood flow
new biomarker linked to blood flow
Detection of glycan shedding in the blood: New class of multiple sclerosis biomarkers?
https://www.frontiersin.org/articles/10 ... 4/abstract
Introduction: Multiple Sclerosis (MS) is a devastating autoimmune disease, afflicting people in the prime of their lives. Presently, after initial clinical presentation there are no reliable markers for whether a given patient will develop MS, or whether their prognosis will be aggressive or relapsing-remitting. Furthermore, many MS patients do not respond to treatment. Thus, markers for diagnosis, prognosis and treatment-responsiveness are lacking for a disease where a precision medicine approach would be valuable. The glycocalyx (GLX) is carbohydrate-rich outer surface of the blood vessel wall and is the first interaction between the blood and the vessel. We hypothesized that cleavage of the GLX may be an early stage predictor of immune attack, blood-brain barrier (BBB) breakdown, and disease severity in MS.
Methods: Two experimental models of MS, experimental autoimmune encephalitis (EAE), were included in this study. EAE was induced in C57BL/6J mice and Lewis rats, which were monitored for weight loss and clinical presentation in comparison to healthy controls. Plasma samples were obtained longitudinally from mice until peak disease severity and at peak disease severity in rats. Soluble GLX-associated glycosaminoglycans (GAG) and proteoglycans (PG) were detected in plasma samples.
Results: All animals receiving EAE emulsion developed fulminant EAE (100% penetrance). Increased plasma levels of chondroitin sulfate were detected before the onset of clinical symptoms and remained elevated. Hyaluronic acid was increased at the height of the disease, whereas heparan sulfate was transiently increased during early stages only. By contrast, syndecans 1, 3, and 4 were detected in EAE samples as well as healthy controls, with no significant differences between the two groups.
Discussion: In this study, we present data supporting the shedding of the GLX as a new class of biomarker for MS. In particular, sugar-based GLX components are associated with disease severity in two models of MS; molecules that would not be detected in proteomics-based screens of MS patient samples. Patient studies are presently underway.
-
- Similar Topics
- Replies
- Views
- Last post
-
-
new biomarker, in blood, and maybe able to classify patients
by frodo » Thu Feb 21, 2019 6:47 pm » in MS Etiology and Pathogenesis - 0 Replies
- 153 Views
-
Last post by frodo
Thu Feb 21, 2019 6:47 pm
-
-
-
Biomarkers: Remains of a retrovirus in blood as biomarker
by frodo » Tue Apr 24, 2018 11:27 pm » in MS Etiology and Pathogenesis - 0 Replies
- 704 Views
-
Last post by frodo
Tue Apr 24, 2018 11:27 pm
-
-
-
eyes blood flow impaired in MS
by frodo » Tue Sep 17, 2019 4:06 am » in Chronic Cerebrospinal Venous Insufficiency (CCSVI) - 0 Replies
- 240 Views
-
Last post by frodo
Tue Sep 17, 2019 4:06 am
-
-
-
Cerebral Blood Flow Changes in Multiple Sclerosis
by frodo » Thu May 24, 2018 8:47 am » in Chronic Cerebrospinal Venous Insufficiency (CCSVI) - 0 Replies
- 1138 Views
-
Last post by frodo
Thu May 24, 2018 8:47 am
-
-
-
Cerebral blood-flow clinical trial
by frodo » Fri May 10, 2019 7:45 am » in Chronic Cerebrospinal Venous Insufficiency (CCSVI) - 2 Replies
- 420 Views
-
Last post by NHE
Wed May 22, 2019 3:24 am
-
-
- 2 Replies
- 185 Views
-
Last post by frodo
Wed Jul 31, 2019 11:08 pm
-
- 2 Replies
- 802 Views
-
Last post by frodo
Tue May 22, 2018 6:46 am
-
-
Biomarker for response to interferon
by frodo » Tue Jan 22, 2019 4:28 am » in MS Etiology and Pathogenesis - 0 Replies
- 211 Views
-
Last post by frodo
Tue Jan 22, 2019 4:28 am
-
-
-
Neurofilament light as biomarker
by frodo » Tue May 28, 2019 6:26 am » in MS Etiology and Pathogenesis - 0 Replies
- 144 Views
-
Last post by frodo
Tue May 28, 2019 6:26 am
-